Incidence, Timing, and Management of Infections in Patients Receiving Daratumumab for the Treatment of Newly Diagnosed Transplant-Ineligible Multiple Myeloma in the MAIA Study

被引：0

作者：

Bahlis, Nizar J. ^{[1
]}

Facon, Thierry ^{[2
,3
]}

Usmani, Saad ^{[4
]}

Moreau, Philippe ^{[5
]}

Raje, Noopur ^{[6
]}

Zweegman, Sonja ^{[7
]}

Chari, Ajai ^{[8
]}

Perrot, Aurore ^{[9
]}

Manier, Salomon ^{[10
]}

Orlowski, Robert ^{[11
]}

Goldschmidt, Hartmut ^{[12
]}

Basu, Supratik ^{[13
,14
]}

Hulin, Cyrille ^{[15
]}

Weisel, Katja ^{[16
]}

Mohty, Mohamad ^{[17
,18
]}

Plesner, Torben ^{[19
,20
]}

Cook, Gordon ^{[21
]}

Leleu, Xavier ^{[22
]}

Quach, Hang ^{[23
]}

Venner, Christopher P. ^{[24
]}

Ngo, Mai ^{[25
]}

Bolyard, Kasey ^{[25
]}

Carson, Robin ^{[25
]}

Borgsten, Fredrik ^{[25
]}

Kumar, Shaji ^{[25
,26
]}

机构：

[1] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[2] Univ Lille, & French Acad Med, Dept Haematol, Paris, France

[3] French Acad Med, Paris, France

[4] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA

[5] Univ Hosp Hotel Dieu, Dept Hematol, Hotel Dieu, France

[6] Massachusetts Gen Hosp, Boston, MA 02114 USA

[7] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Hematol, Amsterdam, Netherlands

[8] Univ Calif San Francisco, San Francisco, CA USA

[9] Ctr Hosp Univ Toulouse, Serv Hematol, Toulouse, France

[10] Univ Lille, Serv Hematol, CHU Lille, Hop Huriez, Lille, France

[11] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[12] Univ Hosp Heidelberg, GMMG Study Grp, Dept Internal Med, Heidelberg, Germany

[13] Royal Wolverhampton NHS Trust, Wolverhampton, W Midlands, England

[14] Wolverhampton Univ, CRN West Midlands, NIHR, Wolverhampton, W Midlands, England

[15] Hop Haut Leveque, Univ Hosp, Dept Hematol, Bordeaux, France

[16] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[17] Sorbonne Univ, Hop St Antoine, Paris, France

[18] INSERM, UMRS938, Paris, France

[19] Vejle Hosp & Univ Southern Denmark, Vejle, Denmark

[20] Univ Southern Denmark, Odense, Denmark

[21] Univ Leeds, Leeds Inst Clin Trials Res, Canc Res UK Clin Trials Unit, Leeds, W Yorkshire, England

[22] CHU Poitiers, Hematol, PRC, Poitiers, France

[23] Univ Melbourne, St Vincents Hosp Melbourne, Melbourne, Vic, Australia

[24] Univ Alberta, Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada

[25] Janssen Res Dev LLC, Lower Gwynedd Township, PA USA

[26] Mayo Clin, Rochester, NY USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-324

引用

页码：S221 / S221

页数：1

共 50 条

[31] The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
Bonello, Francesca
Grasso, Mariella
D'Agostino, Mattia
Celeghini, Ivana
Castellino, Alessia
Boccadoro, Mario
Bringhen, Sara
PHARMACEUTICALS, 2021, 14 (01) : 1 - 14
[32] Negative effect of paraskeletal plasmacytoma on survival of patients with transplant-ineligible newly diagnosed multiple myeloma
Wang, Junzhe
Song, Xiaoning
Zhang, Xian
Liu, Han
Zang, Meirong
Qi, Dianwen
Zhang, Jinqiao
Sun, Lixia
ANNALS OF HEMATOLOGY, 2024, 103 (03) : 917 - 933
[33] Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial
Perrot, Aurore
Facon, Thierry
Plesner, Torben
Usmani, Saad Z.
Kumar, Shaji
Bahlis, Nizar J.
Hulin, Cyrille
Orlowski, Robert Z.
Nahi, Hareth
Mollee, Peter
Ramasamy, Karthik
Roussel, Murielle
Jaccard, Arnaud
Delforge, Michel
Karlin, Lionel
Arnulf, Bertrand
Chari, Ajai
He, Jianming
Ho, Kai Fai
Van Rampelbergh, Rian
Uhlar, Clarissa M.
Wang, Jianping
Kobos, Rachel
Gries, Katharine S.
Fastenau, John
Weisel, Katja
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03) : 227 - +
[34] Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma
Palumbo, A.
Davies, F.
Kropff, M.
Blade, J.
Delforge, M.
da Costa, F. Leal
Garcia Sanz, R.
Schey, S.
Facon, T.
Morgan, G.
Moreau, P.
ANNALS OF HEMATOLOGY, 2010, 89 (08) : 803 - 811
[35] Negative effect of paraskeletal plasmacytoma on survival of patients with transplant-ineligible newly diagnosed multiple myeloma
Junzhe Wang
Xiaoning Song
Xian Zhang
Han Liu
Meirong Zang
Dianwen Qi
Jinqiao Zhang
Lixia Sun
Annals of Hematology, 2024, 103 : 1411 - 1414
[36] Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma
A. Palumbo
F. Davies
M. Kropff
J. Bladé
M. Delforge
F. Leal da Costa
R. Garcia Sanz
S. Schey
T. Facon
G. Morgan
P. Moreau
Annals of Hematology, 2010, 89 : 803 - 811
[37] Symptom burden in transplant-ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study
Mian, Hira S.
Pond, Gregory R.
Wildes, Tanya M.
Sivapathasundaram, Branavan
Sussman, Jonathan
Seow, Hsien
HAEMATOLOGICA, 2021, 106 (07) : 1991 - 1994
[38] Updated Analysis of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): The Phase 3 Maia Study
Kumar, Shaji K.
Facon, Thierry
Usmani, Saad Z.
Plesner, Torben
Orlowski, Robert Z.
Touzeau, Cyrille
Basu, Supratik
Bahlis, Nizar J.
Goldschmidt, Hartmut
O'Dwyer, Michael E.
Venner, Christopher P.
Weisel, Katja
Hulin, Cyrille
Karlin, Lionel
Preis, Meir
Broyl, Annemiek
Renwick, William
Hansson, Markus
Krevvata, Maria
Wang, Jianping
Van Rampelbergh, Rian
Ukropec, Jon
Uhlar, Clarissa M.
Kobos, Rachel
Perrot, Aurore
BLOOD, 2020, 136
[39] Treatment Considerations for Transplant-Ineligible Multiple Myeloma
Elnair, Radowan A.
Holstein, Sarah A.
ONCOLOGY-NEW YORK, 2021, 35 (04): : 170 - 182
[40] Impact on efficacy of the dose and schedule of bortezomib in Transplant-Ineligible Newly Diagnosed Multiple Myeloma
Ibarra, Gladys
Abril, Laura
Pena, Marta
Oriol, Albert
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E235 - E235

← 1 2 3 4 5 →